The Company aims to be 100 per cent Retail Company. IndoStar’s business transition from corporate to retail franchise coincided with Covid. IndoStar however is now at an inflexion point and much closer to a profitable, high growth path than ever before.

The key Indian indices discontinued the three-day winning streak to trade with steep losses and closed in red territory. The weak global cues soured investor sentiment as the higher than expected US inflation data increased fears of aggressive and early rate hikes by the US Federal Reserve. IT, PSU banks, and consumer durables stocks were under pressure. 

Krishna Institute of Medical Science Ltd ( KIMS) surged 5.22 per cent after it announced strong Q3 results yesterday. The Hyderabad based hospital reported a jump of 72 per cent in net profit at Rs 82.22 crore on YoY basis.

Activity in the F&O market for the weekly expiry on February 17 shows 17000 to act as support now.

Mid-size technology company, Mastek Limited has turned multibagger in the past year by delivering a return of 145.27 per cent to its shareholders. The stock closed at Rs 2,722.65 on February 10, 2022, from a low of Rs 1,110.05 on February 10, 2021, thus doubling investor wealth. 

On Friday, the benchmark indices broke three-day gaining momentum and ended lower with Sensex and Nifty contracting 1.31 per cent each.

BSE Small-cap index also closed in the red territory at 28,691.82, recording losses of 1.90 per cent.    

At 1.05, while BSE Sensex was down by 1.22 per cent, these three stocks were trading in green. 

Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Ltd, has announced a strategic tie-up with Mylab Discovery Solutions, India’s leading diagnostic solutions provider. With this association, Shilpa Medicare expects to venture into the vaccine and therapeutics segment

Fear was reflected among the market participants as India VIX surged over 6 per cent.